MiR-320 regulates tumor angiogenesis driven by vascular endothelial cells in oral cancer by silencing neuropilin 1

Angiogenesis

Volumn 17, Issue 1, 2014, Pages 247-260

  Wu, Yi Ying ^a   Chen, Yuh Ling ^a   Jao, Yun Chia ^a   Hsieh, I Shan ^a   Chang, Kung Chao ^a   Hong, Tse Ming ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Angiogenesis; miR 320; Neuropilin 1; Oral cancer

Indexed keywords

GROWTH FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LENTIVIRUS VECTOR; MESSENGER RNA; MICRORNA; MICRORNA 320; NEUROPILIN 1; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ARTICLE; BINDING SITE; CANCER CELL; CARCINOGENICITY; CELL ADHESION; CELL FUNCTION; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; ENDOTHELIUM CELL; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IN VIVO STUDY; MOUTH SQUAMOUS CELL CARCINOMA; NEUROPILIN 1 GENE; PRIORITY JOURNAL; REGULATORY MECHANISM; TAIWAN; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM;

CARCINOMA, SQUAMOUS CELL; CELL MOVEMENT; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HEK293 CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALE; MICRORNAS; MOUTH NEOPLASMS; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; NEUROPILIN-1; RNA, MESSENGER; RNA, NEOPLASM;

EID: 84892736489     PISSN: 09696970     EISSN: 15737209     Source Type: Journal    
DOI: 10.1007/s10456-013-9394-1     Document Type: Article

References (52)

1. Humphreys DT, Westman BJ, Martin DI, Preiss T (2005) MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function. Proc Natl Acad Sci USA 102:16961-16966. doi: 10.1073/pnas.0506482102
2. Wu L, Fan J, Belasco JG (2006) MicroRNAs direct rapid deadenylation of mRNA. Proc Natl Acad Sci USA 103:4034-4039. doi: 10.1073/pnas.0510928103
3. Krol J, Loedige I, Filipowicz W (2010) The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 11:597-610. doi: 10.1038/nrg2843
4. Mendell JT, Olson EN (2012) MicroRNAs in stress signaling and human disease. Cell 148:1172-1187. doi: 10.1016/j.cell.2012.02.005
5. Shenouda SK, Alahari SK (2009) MicroRNA function in cancer: oncogene or a tumor suppressor? Cancer Metastasis Rev 28:369-378. doi: 10.1007/s10555-009- 9188-5
6. Weis SM, Cheresh DA (2011) Tumor angiogenesis: molecular pathways and therapeutic targets. Nat Med 17:1359-1370. doi: 10.1038/nm.2537
7. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10-29. doi: 10.3322/caac.20138
8. da Silva SD, Ferlito A, Takes RP, Brakenhoff RH, Valentin MD, Woolgar JA, Bradford CR, Rodrigo JP, Rinaldo A, Hier MP, Kowalski LP (2011) Advances and applications of oral cancer basic research. Oral Oncol 47:783-791. doi: 10.1016/j.oraloncology.2011.07.004
9. Gorenchtein M, Poh CF, Saini R, Garnis C (2012) MicroRNAs in an oral cancer context - from basic biology to clinical utility. J Dent Res 91:440-446. doi: 10.1177/0022034511431261
10. Gonzalez-Ramirez I, Garcia-Cuellar C, Sanchez-Perez Y, Granados-Garcia M (2011) DNA methylation in oral squamous cell carcinoma: molecular mechanisms and clinical implications. Oral Dis 17:771-778. doi: 10.1111/j.1601-0825.2011. 01833.x
11. Li J, Huang H, Sun L, Yang M, Pan C, Chen W, Wu D, Lin Z, Zeng C, Yao Y, Zhang P, Song E (2009) MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor. Clin Cancer Res 15:3998-4008. doi: 10.1158/1078-0432.CCR-08-3053
12. Childs G, Fazzari M, Kung G, Kawachi N, Brandwein-Gensler M, McLemore M, Chen Q, Burk RD, Smith RV, Prystowsky MB, Belbin TJ, Schlecht NF (2009) Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. Am J Pathol 174:736-745
13. Brahimi-Horn MC, Chiche J, Pouyssegur J (2007) Hypoxia and cancer. J Mol Med (Berl) 85:1301-1307. doi: 10.1007/s00109-007-0281-3
14. Liao D, Johnson RS (2007) Hypoxia: a key regulator of angiogenesis in cancer. Cancer Metastasis Rev 26:281-290. doi: 10.1007/s10555-007-9066-y
15. Parikh AA, Fan F, Liu WB, Ahmad SA, Stoeltzing O, Reinmuth N, Bielenberg D, Bucana CD, Klagsbrun M, Ellis LM (2004) Neuropilin-1 in human colon cancer: expression, regulation, and role in induction of angiogenesis. Am J Pathol 164:2139-2151
16. Hong TM, Chen YL, Wu YY, Yuan A, Chao YC, Chung YC, Wu MH, Yang SC, Pan SH, Shih JY, Chan WK, Yang PC (2007) Targeting neuropilin 1 as an antitumor strategy in lung cancer. Clin Cancer Res 13:4759-4768. doi: 10.1158/1078-0432. ccr-07-0001
17. Hu B, Guo P, Bar-Joseph I, Imanishi Y, Jarzynka MJ, Bogler O, Mikkelsen T, Hirose T, Nishikawa R, Cheng SY (2007) Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway. Oncogene 26:5577-5586. doi: 10.1038/sj.onc.1210348
18. Matsushita A, Gotze T, Korc M (2007) Hepatocyte growth factor-mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1. Cancer Res 67:10309-10316. doi: 10.1158/0008-5472.can-07-3256
19. Lu L, Zhang L, Xiao Z, Lu S, Yang R, Han ZC (2008) Neuropilin-1 in acute myeloid leukemia: expression and role in proliferation and migration of leukemia cells. Leuk Lymphoma 49:331-338. doi: 10.1080/10428190701809149
20. Berge M, Allanic D, Bonnin P, de Montrion C, Richard J, Suc M, Boivin JF, Contreres JO, Lockhart BP, Pocard M, Levy BI, Tucker GC, Tobelem G, Merkulova-Rainon T (2011) Neuropilin-1 is upregulated in hepatocellular carcinoma and contributes to tumour growth and vascular remodelling. J Hepatol 55:866-875. doi: 10.1016/j.jhep.2011.01.033
21. Wey JS, Gray MJ, Fan F, Belcheva A, McCarty MF, Stoeltzing O, Somcio R, Liu W, Evans DB, Klagsbrun M, Gallick GE, Ellis LM (2005) Overexpression of neuropilin-1 promotes constitutive MAPK signalling and chemoresistance in pancreatic cancer cells. Br J Cancer 93:233-241. doi: 10.1038/sj.bjc.6602663
22. Ochiumi T, Kitadai Y, Tanaka S, Akagi M, Yoshihara M, Chayama K (2006) Neuropilin-1 is involved in regulation of apoptosis and migration of human colon cancer. Int J Oncol 29:105-116
23. Rizzolio S, Tamagnone L (2011) Multifaceted role of neuropilins in cancer. Curr Med Chem 18:3563-3575
24. Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M (1998) Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92:735-745
25. Fukasawa M, Matsushita A, Korc M (2007) Neuropilin-1 interacts with integrin beta1 and modulates pancreatic cancer cell growth, survival and invasion. Cancer Biol Ther 6:1173-1180
26. Glinka Y, Stoilova S, Mohammed N, Prud'homme GJ (2011) Neuropilin-1 exerts co-receptor function for TGF-beta-1 on the membrane of cancer cells and enhances responses to both latent and active TGF-beta. Carcinogenesis 32:613-621
27. McCarty MF, Liu W, Fan F, Parikh A, Reimuth N, Stoeltzing O, Ellis LM (2003) Promises and pitfalls of anti-angiogenic therapy in clinical trials. Trends Mol Med 9:53-58
28. Bar J, Onn A (2008) Combined anti-proliferative and anti-angiogenic strategies for cancer. Expert Opin Pharmacother 9:701-715
29. Rogatsch H, Hittmair A, Reissigl A, Mikuz G, Feichtinger H (1997) Microvessel density in core biopsies of prostatic adenocarcinoma: a stage predictor? J Pathol 182:205-210
30. Zhang Y, He X, Liu Y, Ye Y, Zhang H, He P, Zhang Q, Dong L, Liu Y, Dong J (2012) microRNA-320a inhibits tumor invasion by targeting neuropilin 1 and is associated with liver metastasis in colorectal cancer. Oncol Rep 27(3):685-694. doi: 10.3892/or.2011.1561
31. Kitsukawa T, Shimono A, Kawakami A, Kondoh H, Fujisawa H (1995) Overexpression of a membrane protein, neuropilin, in chimeric mice causes anomalies in the cardiovascular system, nervous system and limbs. Development 121:4309-4318
32. Shweiki D, Itin A, Soffer D, Keshet E (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843-845. doi: 10.1038/359843a0
33. Chen SY, Wang Y, Telen MJ, Chi JT (2008) The genomic analysis of erythrocyte microRNA expression in sickle cell diseases. PLoS One 3:e2360. doi: 10.1371/journal.pone.0002360
34. Saba R, Goodman CD, Huzarewich RL, Robertson C, Booth SA (2008) A miRNA signature of prion induced neurodegeneration. PLoS One 3:e3652. doi: 10.1371/journal.pone.0003652
35. Yan LX, Huang XF, Shao Q, Huang MY, Deng L, Wu QL, Zeng YX, Shao JY (2008) MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 14:2348-2360. doi: 10.1261/rna.1034808
36. Chen L, Yan HX, Yang W, Hu L, Yu LX, Liu Q, Li L, Huang DD, Ding J, Shen F, Zhou WP, Wu MC, Wang HY (2009) The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma. J Hepatol 50:358-369. doi: 10.1016/j.jhep.2008.09.015
37. Hsieh IS, Chang KC, Tsai YT, Ke JY, Lu PJ, Lee KH, Yeh SD, Hong TM, Chen YL (2013) MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway. Carcinogenesis 34:530-538. doi: 10.1093/carcin/bgs371
38. Ren XP, Wu J, Wang X, Sartor MA, Qian J, Jones K, Nicolaou P, Pritchard TJ, Fan GC (2009) MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20. Circulation 119:2357-2366. doi: 10.1161/circulationaha.108.814145
39. Wang XH, Qian RZ, Zhang W, Chen SF, Jin HM, Hu RM (2009) MicroRNA-320 expression in myocardial microvascular endothelial cells and its relationship with insulin-like growth factor-1 in type 2 diabetic rats. Clin Exp Pharmacol Physiol 36:181-188
40. Kawasaki T, Kitsukawa T, Bekku Y, Matsuda Y, Sanbo M, Yagi T, Fujisawa H (1999) A requirement for neuropilin-1 in embryonic vessel formation. Development 126:4895-4902
41. Beck B, Driessens G, Goossens S, Youssef KK, Kuchnio A, Caauwe A, Sotiropoulou PA, Loges S, Lapouge G, Candi A, Mascre G, Drogat B, Dekoninck S, Haigh JJ, Carmeliet P, Blanpain C (2011) A vascular niche and a VEGF-Nrp1 loop regulate the initiation and stemness of skin tumours. Nature 478:399-403. doi: 10.1038/nature10525
42. Pan Q, Chanthery Y, Liang WC, Stawicki S, Mak J, Rathore N, Tong RK, Kowalski J, Yee SF, Pacheco G, Ross S, Cheng Z, Le Couter J, Plowman G, Peale F, Koch AW, Wu Y, Bagri A, Tessier-Lavigne M, Watts RJ (2007) Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth. Cancer Cell 11:53-67. doi: 10.1016/j.ccr.2006.10.018
43. Bronisz A, Godlewski J, Wallace JA, Merchant AS, Nowicki MO, Mathsyaraja H, Srinivasan R, Trimboli AJ, Martin CK, Li F, Yu L, Fernandez SA, Pecot T, Rosol TJ, Cory S, Hallett M, Park M, Piper MG, Marsh CB, Yee LD, Jimenez RE, Nuovo G, Lawler SE, Chiocca EA, Leone G, Ostrowski MC (2012) Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320. Nat Cell Biol 14:159-167. doi: 10.1038/ncb2396
44. Brooks PC, Clark RA, Cheresh DA (1994) Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 264(5158):569-571
45. Brooks PC, Montgomery AM, Rosenfeld M, Reisfeld RA, Hu T, Klier G, Cheresh DA (1994) Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79(7):1157-1164
46. Robinson SD, Hodivala-Dilke KM (2011) The role of beta3-integrins in tumor angiogenesis: context is everything. Curr Opin Cell Biol 23(5):630-637. doi: 10.1016/j.ceb.2011.03.014
47. Danhier F, Le Breton A, Preat V (2012) RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis. Mol Pharm 9(11):2961-2973. doi: 10.1021/mp3002733
48. Carmeliet P (2005) VEGF as a key mediator of angiogenesis in cancer. Oncology 69:4-10. doi: 10.1159/000088478
49. Kulshreshtha R, Davuluri RV, Calin GA, Ivan M (2008) A microRNA component of the hypoxic response. Cell Death Differ 15:667-671. doi: 10.1038/sj.cdd.4402310
50. Zhang Z, Sun H, Dai H, Walsh RM, Imakura M, Schelter J, Burchard J, Dai X, Chang AN, Diaz RL, Marszalek JR, Bartz SR, Carleton M, Cleary MA, Linsley PS, Grandori C (2009) MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT. Cell Cycle 8:2756-2768
51. Ishihama H, Ohbayashi M, Kurosawa N, Kitsukawa T, Matsuura O, Miyake Y, Muramatsu T (2001) Colocalization of neuropilin-1 and Flk-1 in retinal neovascularization in a mouse model of retinopathy. Invest Ophthalmol Vis Sci 42:1172-1178
52. Jogi A, Vallon-Christersson J, Holmquist L, Axelson H, Borg A, Pahlman S (2004) Human neuroblastoma cells exposed to hypoxia: induction of genes associated with growth, survival, and aggressive behavior. Exp Cell Res 295:469-487. doi: 10.1016/j.yexcr.2004.01.013